Zepbound
Zepbound is Eli Lilly’s tirzepatide for chronic weight management — and since late 2024, for obstructive sleep apnea in adults with obesity. Same molecule as Mounjaro. LillyDirect’s self-pay vial program made Zepbound the most accessible brand-name GLP-1 for cash-paying patients. Our coverage tracks real Zepbound cost, vial vs pen pricing, and head-to-head with Wegovy.